One trial studied long-term use of oral blood thinning drugs (known as 'antiplatelet drugs') after brain haemorrhage, and another trial compared two different types of antiplatelet drug. Key results ...

The 71-year-old believed the bleeding was a side effect of the antiplatelet drugs he had been taking. Read more at ...

Individual heterogeneity in responsiveness to antiplatelet agents may be due to either inherited or acquired factors. These potential variables include genetic polymorphisms in platelet proteins ...

Anticoagulant drugs or antiplatelet drugs, or both, for reducing the risk of blood clots and stroke in people with antiphospholipid syndrome ...

Some everyday meds may quietly harm your heart. A cardiologist reveals 5 common drugs that could pose hidden risks to your cardiovascular health.

Analysis by Huseyin Naci and colleagues1 overlooks the broader policy context influencing the National Health Service expenditure on branded medicines. The Department of Health, through the Voluntary ...

Obesity remains one of the greatest health challenges worldwide, leading to diabetes, heart disease, and increased healthcare costs. Lifestyle changes and improved diets are critical but often ...

DrugSorb-ATR is designed to reduce the severity of bleeding in patients undergoing coronary artery bypass grafting surgery within two days of stopping the antiplatelet drug Brilinta.

In summary, 9a (vicagrel) holds great promise as a more potent and a safer antiplatelet agent that might have the following advantages over clopidogrel: (1) no drug resistance for CYP2C19 poor ...

Introduction Antiplatelet therapy is commonly used in primary or secondary prevention of atherosclerotic and thrombotic diseases, such as coronary artery disease, transient ischaemic attack or stroke.